Proton Therapy Congress

Lung cancer patients with oliogometastases may benefit from aggressive local therapy, surgery or radiation, after standard chemotherapy, according to research led by The University of Texas MD Anderson Cancer Center.

Elekta and Philips announced the installation of a third high-field (1.5 Tesla) magnetic resonance-guided linear accelerator (MR-linac) system at University Medical Centre (UMC) Utrecht in the Netherlands.

June 6, 2016 — Infinitt North America announced recently that the 2015/2016 Best in KLAS Awards: Software & Services report named Infinitt PACS (picture archiving and communication system) No. 1 Category Leader in PACS (Community) and No. 1 in PACS (Ambulatory). In the PACS, Over 200 Bed category, Infinitt PACS ranked No. 2.

FDA, MQSA, mammography facilities inspectors, training program

A new report from the U.S. Food and Drug Administration (FDA) details the training process for its 200-plus inspectors that perform the annual inspections of over 8,700 mammography facilities.

Agfa HealthCare's Enterprise Imaging platform will be on display at the Society of Imaging Informatics in Medicine (SIIM) 2016 annual meeting, which takes place June 29 - July 1 in Portland, Ore.

June 3, 2016 — Novocure announced that the U.S. Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate the METIS trial. METIS is a multi-center, phase 3, pivotal, open-label study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC).

According to data from a new survey, nearly all of the nation’s hospitals have adopted certified electronic health records (EHRs). The survey was released at the Office of the National Coordinator for Health Information Technology’s (ONC) 2016 annual meeting, May 31-June 2 in Washington, D.C.

A global team of scientists have shown that the brains of patients with schizophrenia have the capacity to reorganize and fight the illness. This is the first time that imaging data has been used to show that our brains may have the ability to reverse the effects of schizophrenia.

June 3, 2016 — Elekta announced that its Leksell Gamma Knife Icon radiosurgery system has been cleared for clinical use by both the Japanese Ministry of Health, Labour and Welfare and the Nuclear Regulatory Commission in the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now